The Lancet HIV in conversation with

81 Episoder

1. HIV vaccines

   Publisert: 29.10.2019
2. Risk prediction and prevention

   Publisert: 30.9.2019
3. Third-line therapy

   Publisert: 4.9.2019
4. Assessing the safety of a PrEP intravaginal ring

   Publisert: 30.7.2019
5. Safer conception for couples living with HIV

   Publisert: 3.7.2019
6. Integrated care for key populations

   Publisert: 2.5.2019
7. Tackling drug use to improve ART adherence

   Publisert: 3.4.2019
8. Measuring adherence to PrEP

   Publisert: 7.1.2019
9. Paediatric HIV in 2018

   Publisert: 1.12.2018
10. PrEP in New South Wales

    Publisert: 27.10.2018
11. HIV outbreak in Indiana

    Publisert: 17.9.2018
12. Internet-based intervention for people with HIV and depressive symptoms

    Publisert: 7.9.2018
13. Enhanced treatment and prevention in sex workers

    Publisert: 7.8.2018
14. HIV-2

    Publisert: 3.7.2018
15. Potential non-disclosed MSM in UK HIV networks

    Publisert: 5.6.2018
16. Journal expansion and early treatment of infants with HIV

    Publisert: 2.5.2018
17. Universal test and treat: The Lancet HIV: November 30, 2017

    Publisert: 1.12.2017
18. PrEP in African women: The Lancet HIV: October 31, 2017

    Publisert: 31.10.2017
19. HIV disparity modelling: The Lancet HIV: April 18, 2017

    Publisert: 19.4.2017
20. HIV in transgender women in Brazil: The Lancet HIV: February 7, 2017

    Publisert: 8.2.2017